Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,235 shares of Class A Common Stock on May 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 12, 2025, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 3,235 shares of Class A Common Stock.
- The sale was executed at a price of $56 per share.
- Following the transaction, Boughton directly owns 156,427 shares of HIMS Class A Common Stock.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Sales by company insiders are routinely monitored by investors. A pre-arranged 10b5-1 trading plan allows corporate insiders to sell company stock without being accused of acting on inside information.
Stakeholder Impact
- The sale of shares by a company officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date the Rule 10b5-1 trading plan was adopted by Soleil Boughton. |
| 05/12/2025 | Date of the transaction: sale of 3,235 shares of Class A Common Stock. |
| 05/13/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Hims & Hers Health, Soleil Boughton, Chief Legal Officer, Stock Sale, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.